Ritonavir: An Extraordinary Example of Conformational Polymorphism
Top Cited Papers
- 1 January 2001
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 18 (6) , 859-866
- https://doi.org/10.1023/a:1011052932607
Abstract
Purpose. In the summer of 1998, Norvir semi-solid capsules supplies were threatened as a result of a new much less soluble crystal form of ritonavir. This report provides characterization of the two...Keywords
This publication has 12 references indexed in Scilit:
- Sulfathiazole polymorphism studied by magic-angle spinning NMRJournal of Pharmaceutical Sciences, 1999
- Demonstration of the Terms Enantiotropy and Monotropy in Polymorphism Research Exemplified by FlurbiprofenJournal of Pharmaceutical Sciences, 1999
- Crystal Forms of Piroxicam Pivalate: Preparation and Characterization of Two PolymorphsJournal of Pharmaceutical Sciences, 1998
- Polymorphism in Anhydrous Theophylline—Implications on the Dissolution Rate of Theophylline TabletsJournal of Pharmaceutical Sciences, 1997
- Polymorphism and Crystallization Behavior of Abbott-79175, a Second-Generation 5-Lipoxygenase InhibitorJournal of Pharmaceutical Sciences, 1996
- Potent Inhibitors of the HIV-1 Protease with Good Oral BioavailabilitiesBiochemical and Biophysical Research Communications, 1995
- ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.Proceedings of the National Academy of Sciences, 1995
- Physical characterization of pharmaceutical solids.Pharmaceutical Research, 1991
- Pharmaceutical Applications of PolymorphismJournal of Pharmaceutical Sciences, 1969
- Polymorphism and Drug AvailabilityJournal of Pharmaceutical Sciences, 1963